NCT04841070View on ClinicalTrials.gov

NEURodevelopmental Outcome After Persistent Pulmonary Hypertension Of the Newborn

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

July 25, 2021

Primary Completion Date

October 29, 2021

Study Completion Date

October 29, 2021

Conditions
Persistent Pulmonary Hypertension of the Newborn
Interventions
OTHER

Ages & Stages Questionnaires®, Third Edition (ASQ3)

Investigators will propose to parents of children hospitalized for the treatment of persistent pulmonary hypertension of the newborn a hetero-evaluation via the validated ASQ questionnaire to analyze neuro-psychomotor development.

Trial Locations (1)

Unknown

CHU Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT04841070 - NEURodevelopmental Outcome After Persistent Pulmonary Hypertension Of the Newborn | Biotech Hunter | Biotech Hunter